Application
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);Application
Figure 1: Western blot analysis using KRT13 mAb against human KRT13 recombinant protein. (Expected MW is 43.4 kDa)Application
Figure 2: Western blot analysis using KRT13 mouse mAb against T47D (1) cell lysate.Application
Figure 3: Flow cytometric analysis of HeLa cells using KRT13 mouse mAb (green) and negative control (red).| Product Name | KRT13 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | K13; CK13 |
| Immunogen | Purified recombinant fragment of human KRT13 (AA: 143-295) expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBFCMICC/IF |
| WB:1:250~1:1000 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Human |
| Alternative Names | K13 CK13 |
|---|---|
| Molecular Weight(MW) | 52kDa |
| Entrez Gene | 3860 |
|---|
Application
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Application
Figure 1: Western blot analysis using KRT13 mAb against human KRT13 recombinant protein. (Expected MW is 43.4 kDa)
Application
Figure 2: Western blot analysis using KRT13 mouse mAb against T47D (1) cell lysate.
Application
Figure 3: Flow cytometric analysis of HeLa cells using KRT13 mouse mAb (green) and negative control (red).| Application Notes | WB:1:250~1:1000 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Purified antibody in PBS with 0.05% sodium azide |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
